Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Study Reveals Link Between Forever Chemicals and Childhood Cancers

There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers, according to a stud

Global Increases in Obesity Set to Continue in Children, Teens to 2050

Globally, increases in obesity are projected to continue to 2050 for children and adolescents, and the prevalence of overweight and obesity is set to increase a

Osteoarthritis Burden Increasing Among Postmenopausal Women

The burden of osteoarthritis (OA) is increasing among postmenopausal women, according to a study published online March 4 in BMJ Global Health. Huadong Xu, from

Stem Cell Therapy Repairs Irreversible Cornea Damage

Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows. can become irreversibly damaged

Lumpectomy Preserves Sexual Well-Being Among Breast Cancer Patients

Opting for a lumpectomy during breast cancer treatment can protect a woman s future sex life, a new study suggests. Breast-conserving therapy (BCT) is associate

Weight Training Best Exercise For Insomnia Among Seniors

Seniors battling insomnia are best off picking up some dumbbells or doing some push-ups, a new evidence review suggests. Resistance exercise, activities that ma

NSAIDs Linked To Lower Dementia Risk

Over-the-counter drugs like aspirin or ibuprofen might help protect against dementia, a new study suggests. These NSAIDs (non-steroidal anti-inflammatory drugs)

Surgery Just Before The Weekend? Bad Idea, Study Says

Folks facing surgery on a Friday may want to consider rescheduling if they can based on findings from a new study. People who undergo surgery just before the we

FDA Grants Orphan Drug Designation for Bexmarilimab in MDS

TURKU, Finland March 3, 2025 Faron Pharmaceuticals Ltd. (AIM FARN, First North FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER-1 receptor t

Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301

Cingulate Inc. (NASDAQ CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR ) drug delivery platform technology to build an

Popular Keywords